Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Amortizatization of Intangibles (2022 - 2025)

Historic Amortizatization of Intangibles for Fennec Pharmaceuticals (FENC) over the last 4 years, with Q3 2025 value amounting to $26000.0.

  • Fennec Pharmaceuticals' Amortizatization of Intangibles rose 400.0% to $26000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $103000.0, marking a year-over-year decrease of 8694.55%. This contributed to the annual value of $800000.0 for FY2024, which is 111212.12% up from last year.
  • Latest data reveals that Fennec Pharmaceuticals reported Amortizatization of Intangibles of $26000.0 as of Q3 2025, which was up 400.0% from $25000.0 recorded in Q2 2025.
  • Fennec Pharmaceuticals' Amortizatization of Intangibles' 5-year high stood at $723000.0 during Q1 2024, with a 5-year trough of $1000.0 in Q1 2022.
  • In the last 4 years, Fennec Pharmaceuticals' Amortizatization of Intangibles had a median value of $22500.0 in 2023 and averaged $68571.4.
  • In the last 5 years, Fennec Pharmaceuticals' Amortizatization of Intangibles skyrocketed by 351500.0% in 2024 and then plummeted by 9640.39% in 2025.
  • Fennec Pharmaceuticals' Amortizatization of Intangibles (Quarter) stood at $15000.0 in 2022, then changed by 0.0% to $15000.0 in 2023, then surged by 73.33% to $26000.0 in 2024, then changed by 0.0% to $26000.0 in 2025.
  • Its Amortizatization of Intangibles was $26000.0 in Q3 2025, compared to $25000.0 in Q2 2025 and $26000.0 in Q1 2025.